SCHEMBL3107782

SCHEMBL3107782

[CH2][C@H](C)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3104684 1.00
SCHEMBL23707 1.00
SCHEMBL21753963 0.96
SCHEMBL29101700 0.96
Magnesium Chloride Anhydrous SCHEMBL29101698 0.87
SCHEMBL29101699 0.87
SCHEMBL17607617 0.83 METAP1 (0.36)
SCHEMBL10526775 0.81 TSHR (0.33)
SCHEMBL1972172 0.81 TSHR (0.46)
SCHEMBL83492 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0640142-B1 PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR PFIZER (US) 1998-05-20 EP claimed
EP-0640142-A1 PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR PFIZER INC. (US) 1995-03-01 EP claimed
WO-1993019194-A1 PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR PFIZER INC. (US) 1993-09-30 WO claimed
EP-0284176-B1 PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR PFIZER INC. (US) 1993-08-25 EP claimed
EP-0284176-A2 Process for production of avermectins and cultures therefor PFIZER INC. (US) 1988-09-28 EP claimed
US-4767743-A ANTIINFECTION AGENTS PFIZER INC. (US) 1988-08-30 US claimed
EP-2888586-A1 SYSTEM AND METHOD FOR DETECTING OF ALPHA-METHYLACYL-COA RACEMASE (AMACR) AND PROSTATE CANCER Case Western Reserve University (US) 2015-07-01 EP disclosed
WO-2014032044-A1 SYSTEM AND METHOD FOR DETECTING OF ALPHA-METHYLACYL-COA RACEMASE (AMACR) AND PROSTATE CANCER CASE WESTERN RESERVE UNIVERSITY (US) 2014-02-27 WO disclosed
US-20100256098-A1 COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2010-10-07 US disclosed
EP-2188296-A1 COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS The United States Of America, As Represented By The Secretary, Department Of Health And Human Services (US) 2010-05-26 EP disclosed
WO-2009136001-A1 PROTEIN KINASE MODULATING AGENTS TUOMINEN RAIMO (FI) 2009-11-12 WO disclosed
WO-2009029844-A1 COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2009-03-05 WO disclosed
EP-1805322-A4 ENZYME CYCLING BASED ASSAYS FOR ALPHA-METHYLACYL-CoA RACEMASE GEN ATOMICS (US) 2008-10-08 EP disclosed
US-5650534-A Optically active smectic photo-cross-linkable liquid crystals ROLIC AG (CH) 1997-07-22 US disclosed
EP-0699731-A2 Optically avtive smectic photo-curable liquid crystals F. HOFFMANN-LA ROCHE AG (CH) 1996-03-06 EP disclosed
US-4980082-A DISPLAY ELEMENTS; HIGH SPEED RESPONSE TO ELECTRICAL FIELDS SEIKO INSTRUMENTS INC. (JP) 1990-12-25 US disclosed
EP-0227306-B1 PEPTIDE IMMUNOSTIMULANTS PFIZER INC. (US) 1989-09-13 EP disclosed
US-4767743-A ANTIINFECTION AGENTS PFIZER INC. (US) 1988-08-30 US disclosed
EP-0262809-A1 Pyrimidinylphenyl ester compound TEIKOKU CHEMICAL INDUSTRY CO., LTD. (JP) 1988-04-06 EP disclosed
EP-0227306-A2 Peptide immunostimulants PFIZER INC. (US) 1987-07-01 EP disclosed